Relapsing-Remitting Multiple Sclerosis clinical trials in California
6 active Relapsing-Remitting Multiple Sclerosis trials with a site in California. Describe your situation to see which ones look like a fit.
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcutaneous Formulation of Ocrelizumab in Participants With Multiple Sclerosis
- Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
- Care in Multiple Sclerosis (MS)
- Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis
- Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis
- Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.